pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

2,194 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT979Endpoints752BioPharma Dive287BioSpace188Fierce Biotech182onclive165globenewswire health73raps
therapy area
allOncology5740Rare Disease1267Cardiology1065Immunology967Hematology952Pulmonology849Vaccines
  • Alcohol Use Remains Leading Cause of Death in U.S., New Data Highlights Hidden Epidemic
    STAT's latest series reveals that alcohol kills more Americans each year than all illicit drugs combined, yet it remains largely overlooked by health officials and the public. Ten charts illustrat…
    STAT · 1mo agoNegative↗ source
  • AI competition shows better data beats larger models in drug metabolism predictions
    Inductive Bio emerged as the winner of a recent drug metabolism AI competition, but the final standings revealed a 28-way statistical tie, underscoring that the quality of data can outweigh model s…
    STAT · 1mo agoPositive readoutPositive↗ source
← prev
page 36 of 88
next →
66
fda recalls43
fda medwatch32
fda press25
826
Psychiatry & CNS698
Ophthalmology394
Pain347
Endocrinology & Metabolism343
Infectious Disease336
  • Anthropic launches Claude Science AI platform for biotech labs in Kendall Square
    Anthropic has introduced Claude Science, an application that tailors its large language model for use in biopharma research laboratories. The tool is being positioned for the Kendall Square biotech…
    STAT · 1mo agoNeutral↗ source
  • California settles with bankrupt Carbon Health, signaling crackdown on digital health workarounds
    At the end of June, California's attorney general reached a settlement with Carbon Health, a clinic operator that has filed for bankruptcy. The settlement follows accusations from the state Justic…
    Endpoints · 1mo agoRegulatoryNegative↗ source
  • Former Akero executives team up with Fairmount to launch new immunology company
    The former executive team of Akero Therapeutics, which was recently acquired by Novo Nordisk, has announced the formation of a new immunology-focused company. They are partnering with investment fi…
    STAT · 1mo agoNeutral↗ source
  • US appeals court revives Teva lawsuit alleging Lilly breached generic Forteo agreement
    A U.S. appeals court has revived a lawsuit filed by Teva Pharmaceuticals against Eli Lilly. The case alleges that Lilly broke an agreement that permitted Teva to sell a generic version of Lilly's o…
    STAT · 1mo agoNegative↗ source
  • Draig Therapeutics raises $65 million Series B to push depression drug targeting synapse repair
    Draig Therapeutics announced it has closed a $65 million Series B financing round that was oversubscribed. The capital will be used to advance its neuropsychiatry pipeline, with the lead program f…
    Endpoints · 1mo agoDealPositive↗ source
  • Lyora Therapeutics launches to revive early-stage genetic eye disease programs from Editas and Biogen
    Lyora Therapeutics announced its formation as a new genetic‑medicine company focused on eye diseases. The firm will take over several early‑stage programs that were previously in the pipelines of E…
    Endpoints · 1mo agoPositive↗ source
  • Former Akero executives launch Avere Therapeutics, unveiling China-sourced pipeline drug and reverse merger plan
    The former leadership team of Akero Therapeutics announced the creation of a new in‑licensing company called Avere Therapeutics. The launch was made public on Tuesday and includes a pipeline drug…
    Endpoints · 1mo agoDealNeutral↗ source
  • Cyclospora infections hit record high in 2026, Michigan officials suspect lettuce as source
    Infections caused by the parasite Cyclospora have surged to a record level in 2026, with more than 30 states reporting cases that now exceed the previous U.S. high of about 4,700 set in 2019. The…
    STAT · 1mo agoNegative↗ source
  • Democratic senators raise concerns over credibility and conflicts in RFK Jr.'s health-care advisory panel
    Two senior Democratic senators sent a letter to Health Secretary Robert F. Kennedy Jr. and CMS Administrator Mehmet Oz, saying they have serious concerns about the credibility and financial conflic…
    STAT · 1mo agoRegulatoryNegative↗ source
  • BIO 2026 in San Diego features executive interviews on biotech trends and opportunities
    The BIO International Convention gathered more than 20,000 life‑science leaders in San Diego, serving as a major forum for biotech discussion. During the event, Fierce conducted a series of video…
    Fierce Biotech · 1mo agoNeutral↗ source
  • Newborn vitamin K refusal linked to bleeding risk as Ebola center workers strike over unpaid wages
    A recent STAT newsletter highlighted the dangers of declining the standard vitamin K injection for newborns, noting that refusal can increase the chance of serious bleeding in infants. The piece e…
    STAT · 1mo agoNeutral↗ source
  • STAT outlines 12 actionable steps to curb U.S. alcohol-related deaths
    STAT's investigative series examined the U.S. alcohol epidemic by interviewing over a hundred researchers, clinicians, patients, industry insiders and lawmakers. The reporters also reviewed scienti…
    STAT · 1mo agoPositive↗ source
  • Experts hail new pancreatic cancer drug daraxonrasib as biggest breakthrough in decades
    A conference in London brought together international pancreatic cancer researchers to discuss the latest advances. The meeting quickly shifted focus when a new drug, daraxonrasib, was highlighted…
    STAT · 1mo agoPositive↗ source
  • States' Medicaid cuts threaten financial stability of family caregivers for disabled adults
    Several states are proposing steep reductions in wages for family caregivers who provide care to people with disabilities as they grapple with Medicaid funding shortfalls. The article highlights t…
    STAT · 1mo agoRegulatoryNegative↗ source
  • AIDS activists criticize Biden-Gilead R&D settlement over HIV prevention patents
    A group of AIDS activists have secured an R&D agreement that sits at the core of a settlement between the U.S. government and Gilead Sciences concerning patents on HIV prevention drugs. The activi…
    STAT · 1mo agoRegulatoryNegative↗ source
  • FDA issues final guidance for psychedelic drug developers and announces public hearing
    The FDA has completed a set of clinical guidance documents aimed at companies developing psychedelic medicines. The guidance outlines expectations for trial design, safety monitoring, and data col…
    Endpoints · 1mo agoRegulatoryPositive↗ source
  • Digital health funding jumps to $7.4 billion in first half of 2026
    Digital health startups secured $7.4 billion in venture capital during the first six months of 2026, according to research firm Rock Health. This represents a $1 billion increase compared with the…
    Endpoints · 1mo agoDealPositive↗ source
  • Biopharma M&A Surge Sets Tone for 2026 Earnings Season
    The biopharma sector is entering the second half of 2026 after a year marked by unusually high merger and acquisition activity. Companies have been busy negotiating and closing deals, signaling con…
    Endpoints · 1mo agoDealNeutral↗ source
  • Ohio launches $30M Life Science Training Center to boost biomanufacturing workforce
    Ohio’s JobsOhio agency and the Ohio Life Sciences Association announced a public-private training center backed by up to $30 million. The center is intended to create a statewide pipeline of operat…
    Fierce Biotech · 1mo agoPositive↗ source
  • FDA issues complete response letter rejecting Tris Pharma’s narcolepsy candidate; Agenus halts Phase 3 colorectal cancer trial
    The U.S. Food and Drug Administration sent Tris Pharma a complete response letter for its experimental treatment for narcolepsy, stating that additional data are required before approval can be con…
    Endpoints · 1mo agoCRLNegative↗ source
  • US faces critical shortage of forensic pathologists, delaying justice and public health
    The United States is experiencing a severe deficit of forensic pathologists, with roughly 850 currently practicing-about 400 fewer than experts say are needed to handle more than three million deat…
    STAT · 1mo agoNegative↗ source
  • Dementia prevention trial in Latin America replicates earlier promising results with culturally tailored risk-reduction program
    A new dementia prevention study presented at the Alzheimer’s Association International Conference showed results that mirror earlier findings, reinforcing the value of structured risk‑reduction pro…
    STAT · 1mo agoPositive readoutPositive↗ source
  • UnitedHealth touts home-care audit but its 97% justification claim faces scrutiny as insurers sue CMS over MA ratings
    UnitedHealth Group promoted a new audit that claims 97% of diagnoses recorded for its Medicare Advantage members during home visits are supported by medical records. The company presented the findi…
    STAT · 1mo agoRegulatoryNegative↗ source